Associated Press - December 28, 2007
Yuri Kageyama

The agreement is a landmark victory in the five-year legal battle of some 200 hepatitis C patients, who had filed lawsuits in several courts, accusing the government of approving the blood products while knowing of their possible dangers.

The blood-clotting agents were administered to stop bleeding during surgery and childbirth from the 1970s to the early 1990s - infecting possibly thousands more people with hepatitis C, a chronic, potentially lethal blood-borne virus that can cause liver ailments, including cancer and liver failure.

The government is suspected of irresponsibly continuing to approve the products in Japan, long after they were discontinued in the U.S. in 1977 because of the dangers. Outbreaks in Japan of hepatitis C linked to the administering of such drugs were reported as early as the mid-1980s, and the risks are believed to have been widely known in medical circles.

Under the new agreement between the plaintiffs' attorneys and a panel of lawmakers, a bill will be passed to offer compensation to about 1,000 people with hepatitis C, earmarking from $106,000 to $354,000 per person, depending on the severity of their ailments, a Health Ministry official said.

He requested anonymity, as is customary here when an official is not the spokesman. The bill will be worded to admit government responsibility and offer an apology, he said.

The plaintiffs earlier rejected a proposed out-of-court settlement because it did not include an acknowledgment of government responsibility - the biggest sticking point in the ongoing negotiations.

Their tearful appeals before cameras dominated TV and other media coverage in Japan in recent months - swaying public opinion to their side while sending the popularity polls of Prime Minister Yasuo Fukuda plunging.

Earlier this month, Fukuda did an about-face and apologized to the plaintiffs.

Although Japan prides itself on strict regulations over food, pharmaceuticals and other products, the nation has also had its share of scandals that have highlighted ineptitude and irresponsibility at high places.

Japan was mired in a similarly stunning scandal over blood products in the 1990s, which were tainted with the HIV virus but were approved by the government for routine use for hemophiliacs - even after reports of their risks surfaced. About 1,800 people were infected, and hundreds died.

As many as 10,000 Japanese are believed to have been infected by hepatitis C through the tainted products, but that number could be as many as 2 million, Japanese media reports said.

071228
AP071257

Copyright © 2007 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .